PHARMING GRP SP. ADRS (PHG) — Capital Reinvestment Ratio
PHARMING GRP SP. ADRS (PHG) has a Capital Reinvestment Ratio of 0.03x as of December 2025, meaning it reinvests 0% of its operating cash flow (€10.71 Million) in capital expenditures (€269.00K). Check tangible net worth ratio of PHARMING GRP SP. ADRS to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
PHARMING GRP SP. ADRS Capital Reinvestment Ratio (2021–2025)
This chart tracks PHARMING GRP SP. ADRS's Capital Reinvestment Ratio across 3 annual periods. For the full cash flow conversion analysis, see PHG operating cash flow.
Annual Capital Reinvestment Ratio for PHARMING GRP SP. ADRS (2021–2025)
Year-by-year Capital Reinvestment Ratio for PHARMING GRP SP. ADRS from 2021 to 2025. See how much free cash does PHARMING GRP SP. ADRS generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | €54.71 Million | €755.00K | ▼ -84.3% |
| 2022 | 0.09x | €22.46 Million | €1.98 Million | ▼ -80.1% |
| 2021 | 0.44x | €37.84 Million | €16.72 Million | — |